Suppr超能文献

Navigating dry eye relief: Meibo's approach to controlling tear evaporation.

作者信息

Ahmed Bisma, Shahzad Yumna, Urooj Wajiha, Siddiqui Amal, Nisa Mughal Zaib Un, Abbasher Hussien Mohamed Ahmed Khabab

机构信息

Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.

Faculty of Medicine, University of Khartoum, Khartoum, Sudan.

出版信息

Ann Med Surg (Lond). 2024 Sep 10;86(10):5680-5684. doi: 10.1097/MS9.0000000000002550. eCollection 2024 Oct.

Abstract
摘要

相似文献

1
Navigating dry eye relief: Meibo's approach to controlling tear evaporation.
Ann Med Surg (Lond). 2024 Sep 10;86(10):5680-5684. doi: 10.1097/MS9.0000000000002550. eCollection 2024 Oct.
5
Tear flow and evaporation in patients with and without dry eye.
Ophthalmology. 1996 Apr;103(4):664-9. doi: 10.1016/s0161-6420(96)30637-4.
6
Addressing excessive evaporation: an unmet need in dry eye disease.
Am J Manag Care. 2023 Oct;29(13 Suppl):S239-S247. doi: 10.37765/ajmc.2023.89448.
7
Effectiveness of dry eye therapy under conditions of environmental stress.
Curr Eye Res. 2013 Feb;38(2):229-36. doi: 10.3109/02713683.2012.757323. Epub 2013 Jan 7.
8
Aqueous deficiency is a contributor to evaporation-related dry eye disease.
Eye Vis (Lond). 2020 Feb 1;7:6. doi: 10.1186/s40662-019-0172-z. eCollection 2020.
9
Tear physiology of aqueous deficiency and evaporative dry eye.
Optom Vis Sci. 2009 Nov;86(11):1235-40. doi: 10.1097/OPX.0b013e3181bc63cc.
10
Provocation of the ocular surface to investigate the evaporative pathophysiology of dry eye disease.
Cont Lens Anterior Eye. 2021 Feb;44(1):24-29. doi: 10.1016/j.clae.2020.03.014. Epub 2020 Apr 20.

本文引用的文献

1
Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease.
Drugs. 2024 Apr;84(4):441-448. doi: 10.1007/s40265-024-02016-5. Epub 2024 Mar 30.
3
Prevalence and associated risk factors of dry eye disease in Hotan, Xinjiang: a cross-sectional study.
BMC Ophthalmol. 2023 May 15;23(1):214. doi: 10.1186/s12886-023-02955-9.
4
NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study.
Am J Ophthalmol. 2023 Aug;252:265-274. doi: 10.1016/j.ajo.2023.03.008. Epub 2023 Mar 21.
5
Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape.
Ophthalmol Ther. 2023 Jun;12(3):1397-1418. doi: 10.1007/s40123-023-00669-1. Epub 2023 Mar 1.
6
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
Ophthalmology. 2023 May;130(5):516-524. doi: 10.1016/j.ophtha.2022.12.021. Epub 2022 Dec 24.
7
Current trends in pharmaceutical treatment of dry eye disease: A review.
Eur J Pharm Sci. 2022 Aug 1;175:106206. doi: 10.1016/j.ejps.2022.106206. Epub 2022 May 11.
8
DRY EYE DISEASE. A REVIEW.
Cesk Slov Oftalmol. 2021 Winter;77(3):107–119. doi: 10.31348/2020/29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验